AAP 2011: Speaking with Dr. Natasha Gerbert [Video]

Article

One of the great thing about covering a medical conference is being able to interact with physicians and thought leaders about the hot topics in their specialty. In this video, Natasha Bergert, MD, a pediatrician from Kansas City, MO, discusses her experience at this year's AAP conference.

One of the great thing about covering a conference is being able to interact with physicians and thought leaders about the hot topics in their specialty. In this video, Natasha Bergert, MD, a pediatrician from Kansas City, MO, discusses her experience at the 2011 American Academy of Pediatrics in Boston.

Read more about what Dr. Begert has to say by visiting her blog, KCKidsDoc and make sure to follow her on Twiiter @DoctorNatasha. Special thanks to Dr. Gerbert for speaking with HCPLive.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Related Content
| Image Credit: California Retina Consultants

Sozinibercept Combination Therapy Exhibits Durability for nAMD, DME

Connor Iapoce
July 25th 2024
Article
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 3rd 2024
Podcast
FDA Accepts sBLA for Susvimo in Treatment of DME, Diabetic Retinopathy | Image Credit: US Food and Drug Administration

FDA Accepts sBLA for Susvimo in Treatment of DME, Diabetic Retinopathy

Connor Iapoce
July 23rd 2024
Article
Carol Levy, MD | Credit: T1D Exchange

Diabetes Dialogue: Patient Considerations for Inhaled Insulin, with Carol Levy, MD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
June 30th 2024
Podcast
Michael Gorin, MD | Credit: UCLA

Once-Daily Gildeuretinol Acetate Could Halt Progression of Early Stargardt Disease

Patrick Campbell
July 21st 2024
Article
NEPTUNE: Oral Brepocitinib Effective in Non-infectious Uveitis at 24 Weeks

NEPTUNE: Oral Brepocitinib Effective in Non-infectious Uveitis at 24 Weeks

Connor Iapoce
July 20th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.